AD
Trelagliptin succinate(CAS: 1029877-94-8)
CAS Number
Related Products
![Sodium 6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate](https://static.chemtradehub.com/structs/184/1847-24-1-ed76.webp)
![(6R,7R)-7-Amino-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://static.chemtradehub.com/structs/242/24209-38-9-0e4a.webp)
![(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://static.chemtradehub.com/structs/650/65052-63-3-0cb0.webp)
![1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]-](https://static.chemtradehub.com/structs/120/120014-07-5-6ad9.webp)
![Isopropyl (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-4-fluoro-3-hydroxy-4-methyltetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name)](https://static.chemtradehub.com/structs/119/1190307-88-0-40ef.webp)
![(2S,5R,6R)-6-({[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid](https://static.chemtradehub.com/structs/525/5250-39-5-6dba.webp)
Other Suppliers for Trelagliptin succinate
Basic Information
Molecular Formula
C22H26FN5O6
Molecular Weight
135.12 g/mol
Chemical Identifiers
SMILES
CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N.C(CC(=O)O)C(=O)O
InChIKey
OGCNTTUPLQTBJI-XFULWGLBSA-N
Database References
MDL Number
MFCD22665720
FAQ
Trelagliptin succinate (CAS: 1029877-94-8) is a pharmaceutical compound used as a DPP-4 inhibitor. It has the chemical formula C25H31N5O7S and is known for its stability in solid form. This compound is characterized by its role in enhancing glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) levels, making it effective for managing type 2 diabetes.
Trelagliptin succinate (CAS: 1029877-94-8) is primarily used in pharmaceuticals to treat type 2 diabetes. As a DPP-4 inhibitor, it helps regulate blood sugar by prolonging the activity of incretin hormones. It is also utilized in research for studying metabolic disorders and in drug development for diabetes therapies.
Trelagliptin succinate (CAS: 1029877-94-8) is generally safe when used as directed, with minimal toxicity in therapeutic doses. Safety measures include avoiding misuse and following guidelines for handling during storage or synthesis. It meets pharmaceutical safety standards, but like all medications, it may cause side effects such as hypoglycemia or gastrointestinal issues in some patients.
Trelagliptin succinate (CAS: 1029877-94-8) should be stored in a cool, dry place, away from direct light. Maintain temperature between 2-8°C (36-46°F) and protect from moisture by using airtight containers. Proper storage ensures stability and prevents degradation, adhering to pharmaceutical quality and safety protocols.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
